◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06082687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Tissue |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2022-09-14 |
| Primary Completion | 2027-09 |
Trial Parameters
Condition Tissue
Sponsor University of Central Florida
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-09-14
Completion 2027-09
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Eligibility Criteria
Inclusion: \- de-identified human tissue from cooperating institutions for unknown/undisclosed donors.
Related Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology